Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174]
Discontinued
Reference number: GID-TA10377
Following notification from the company, this appraisal has been delayed. The new timelines will be confirmed subsequently.
As this appraisal has been referred, NICE will continue to monitor any development and will update interested parties as and when the situation changes.